Soo Bong Han

USPTO Granted Patents = 8 (Patent Applications = 6)

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 5 (Patent Applications = 14)

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 13(Granted Patents)

Location History:

Daejeon-si, KR (2017 - 2018)
Daejeon, KR (2016 - 2024)

Company Filing History:

8 out of 624

Korea Research Institute of Chemical Technology

patents

5 out of 238

Katholieke Universiteit Leuven, Ku Leuven R&d

patents

3 out of 346

Katholieke Universiteit Leuven

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12286423 - Antiviral 1,3-di-oxo-indene compounds (2025-04-29),

2. 12083092 - Antiviral 1,3-di-oxo-indene compounds (2024-09-10),

3. 9951058 - Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (2018-04-24),

4. 9890133 - Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases (2018-02-13),

5. 9833423 - 1,3-Di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient (2017-12-05),

6. 9790197 - Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (2017-10-17),

7. 9464067 - Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases (2016-10-11),

8. 9346749 - 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient (2016-05-24),

Title: The Innovations of Soo Bong Han

Introduction

Soo Bong Han is a prominent inventor based in Daejeon-si, South Korea. He has made significant contributions to the field of chemical technology, particularly in the development of antiviral compounds. With a total of eight patents to his name, Han's work has garnered attention in both academic and industrial circles.

Latest Patents

Among his latest innovations are the antiviral 1,3-di-oxo-indene compounds. These compounds, described in his patents, provide a novel approach to combating viral infections. The invention outlines compounds of Formula (I), showcasing their potential therapeutic applications.

Career Highlights

Soo Bong Han has had a distinguished career, working at notable institutions such as the Korea Research Institute of Chemical Technology and Katholieke Universiteit Leuven. His research has focused on advancing chemical technologies that can lead to significant health benefits.

Collaborations

Throughout his career, Han has collaborated with esteemed colleagues, including Hae Soo Kim and Johan Neyts. These partnerships have contributed to the success of his research and the development of innovative solutions in the field.

Conclusion

Soo Bong Han's contributions to the field of chemical technology and his innovative antiviral compounds highlight his role as a leading inventor. His work continues to influence research and development in the industry.

This text is generated by artificial intelligence and may not be accurate.